Independent prognostic value of elevated C-reactive protein in unstable angina

Circulation

Volumn 100, Issue 19, 1999, Pages 1958-1963

  Ferreiró, Ernesto R ^a   Boissonnet, Carlos P ^a   Pizarro, Rodolfo ^a   García Merletti, Pablo F ^a   Corrado, Gianni ^a   Cagide, Arturo ^a   Bazzino, Oscar O ^a  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

Author keywords

Angina; Prognosis; Proteins

Indexed keywords

C REACTIVE PROTEIN;

AGED; ARTICLE; CLINICAL FEATURE; DISEASE MARKER; ELECTROCARDIOGRAM; FEMALE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; UNSTABLE ANGINA PECTORIS;

EID: 0033539593     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.cir.100.19.1958     Document Type: Article

References (23)

1. Constantinides P. Plaque fissures in human coronary thrombosis. J Atheroscler Res. 1966;6:1-17.
2. Davies JM, Thomas AC. Thrombosis and acute coronary artery lesion in sudden cardiac ischemic death. N Engl J Med. 1984;310:1137-1140.
3. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death: autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation. 1985;50:127-134.
4. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:242-250.
5. Van der Wal AC, Becker AE, van der Los CH, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36-44.
6. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation. 1994;90:775-778.
7. Shah PK, Falk E, Badimon JJ, Fernandez-Ortiz A, Mailhac A, Villareal-Levy G, Fallon JT, Regnstrom J, Fuster V. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques: potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation. 1995;92: 1565-1569.
8. Mazzone A, De Servi S, Ricevuti G, Mazzucchelli I, Fossati G, Pasotti F, Specchia G, Notario A. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation. 1993;22:358-363.
9. Biasucci LM, D'Onofrio G, Liuzzo G, Zini G, Caligiuri G, Monaco C, Rebuzzi AG, Bizzi RB, Maseri A. Intracellular neutrophil myeloper-oxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia. J Am Coll Cardiol. 1996;27: 611-616.
10. Berck BC, Weintraub W, Alexander RW. Elevation of C reactive protein in "active" coronary disease. Am J Cardiol. 1990;65:168-172.
11. Braunwald E. Unstable angina: a classification. Circulation. 1989;80: 410-414.
12. US Department of Health and Human Services, Public Health Service. Unstable Angina: Diagnosis and Management. Clinical Practice Guidelines, No. 10. Rockville, Md: Agency for Health Care Policy and Research and National Heart, Lung, and Blood Institute; 1994.
13. Bazzino O, Tajer C, Paviotti C, Mele E, Trivi M, Piombo A, Hirshon Prado A, Paolasso E. Clinical predictors of in-hospital prognosis in unstable angina: ECLA 3. Am Heart J. 1999;137:322-331.
14. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med. 1994;331: 417-424.
15. Toss H, Lindhal B, Siegbahn A, Wallentin L. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. Circulation. 1997;96:4204-4210.
16. Ridker PM, Cushmen M, Stampfer MJ, Tracy R, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-1014.
17. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. Recommendations for quantitation of the left ventricle by 2-dimensional echocardiography. J Am Soc Echocardiogr. 1989;2:358-367.
18. Coplan NL, Wallach ID. The role of exercise testing for evaluating patients with unstable angina. Am Heart J. 1992;124:252-256.
19. Moss AJ, Goldstein RE, Jackson Hall W, Bigger T, Fleiss JL, Greenberg H, Bodenheimer M, Kroner RJ, Marcus FI, Wackers FJ, Gillespie JA, Gregory JJ, Kleiger R, Lichstein E, Parker JO, Raubertas RF, Stern S, Tzivoni D, van Voorhees L. Detection and significance of myocardial ischemia in stable patients after recovery from an acute coronary event. JAMA. 1993;269:2379-2385.
20. Lauer MS. Noninvasive risk stratification after myocardial infarction: which test is best? Am Heart J. 1998;136:565-569.
21. Morrow DA, Rifai N, Antman AN, Weiner DL, McCabe CH, Cannon CP, Braunwald E. C-reactive protein is a potent predictor of mortality independently or in combination with troponin T in acute coronary syndromes: a TIMI 11 substudy. J Am Coll Cardiol. 1998;31:1460-1465.
22. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet. 1997;349:462-466.
23. Montalescot G, Philippe F, Ankri A, for the French Investigators of the ESSENCE Trial. Early increase of von Willebrand Factor predicts adverse outcome in unstable coronary artery disease. Circulation. 1998; 98:294-299.